Skip to main content
. 2012 Jul 4;8(3):515–520. doi: 10.5114/aoms.2012.28639

Table II.

Comparison of severe asthma subgroups

Feature A-RO A-IRO Value of p
ACT [points] 12.4±1.7 13.2±1.4 NS
Oral steroid-free days [%] 0 (0-0) 0±0 100 (0-100) 57±13
Symptom-free days [%] 0 (0-0) 0 (0-0)
Days with diurnal PEF variability > 20% [%] 6±4 19±8 NS
ESR [mm/h] 6.8±1.6 10.2±2.5 NS
CRP 2.2±0.5 6.3±2.6 NS
IgE total 255.5±121.7 145.2±48.1 NS
Patients with positive specific IgE [%] 83 58 NS

A-RO – asthma reversible obstruction subgroup, A-IRO – asthma irreversible obstruction subgroup, ACT – asthma control test, ACT – asthma control tests, ESR – erythrocyte sedimentation rate, CRP – C-reactive protein, IgE – immunoglobulin E